TMEM63B

Chr 6AD

transmembrane protein 63B

Also known as: C6orf110, DEE118, hTMEM63B

Enables mechanosensitive monoatomic cation channel activity. Predicted to be involved in sensory perception of sound and surfactant secretion. Located in actin cytoskeleton; cytoplasmic vesicle membrane; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

OMIMResearchGenerating clinical summary…
GOFmechanismADLOEUF 0.171 OMIM phenotype
Clinical SummaryTMEM63B
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 92 VUS of 150 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.17LOEUF
pLI 1.000
Z-score 5.88
OE 0.07 (0.030.17)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.22Z-score
OE missense 0.48 (0.430.53)
243 obs / 511.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.07 (0.030.17)
00.351.4
Missense OE?0.48 (0.430.53)
00.61.4
Synonymous OE?1.10
01.21.6
LoF obs/exp: 3 / 46.1Missense obs/exp: 243 / 511.4Syn Z: -1.14
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateTMEM63B-related developmental and epileptic encephalopathy with anemiaGOFAD

This gene — mechanism propensity

DN
0.4289th %ile
GOF
0.6932th %ile
LOF
0.53top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.17
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

150 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic3
VUS92
Likely Benign13
Benign1
Conflicting1
4
Pathogenic
3
Likely Pathogenic
92
VUS
13
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
4
0
0
4
Likely Pathogenic
0
3
0
0
3
VUS
5
87
0
0
92
Likely Benign
0
4
1
8
13
Benign
0
0
0
1
1
Conflicting
1
Total59819114

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap TMEM63B — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TMEM63B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →